| Nicholas Zakovich, | |
|
401 Railroad St W, Missoula, MT 59802-4109 | |
| (406) 258-4789 | |
| (406) 258-4732 |
| Full Name | Nicholas Zakovich |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 401 Railroad St W, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215490081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 116217 (Montana) | Primary |
| Entity Name | Benefis Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780968974 PECOS PAC ID: 1153235296 Enrollment ID: O20100629000044 |
News Archive
New research published Online First in The Lancet indicates that babies born to mothers who are overweight or obese in sub-Saharan Africa, where rates of obesity are projected to increase at an alarming rate during the next two decades, are significantly more likely to die in the first two days after their birth. The study is the first to shed light on the role of maternal obesity in neonatal death (during the first 28 days of life) in developing countries.
Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Upconversion emission materials are ideal for bioimaging due to its effectiveness as contrast agents for the detection of cancer cells, more so when the background emission of non-cancerous tissues can be minimised. These materials could be used as biomarkers for luminescent labeling of cancerous cells. Opaque tissues can be turned into glassy, transparent substances by using these biomarkers which rely on near-infrared excitation.
HIV-positive people who received healthy food and snacks for six months were more likely to adhere to their medication regimens, and they, as well as people with type 2 diabetes, were less depressed and less likely to make trade-offs between food and healthcare, according to a new study led by researchers at UC San Francisco.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Zakovich, 401 Railroad St W, Missoula, MT 59802-4109 Ph: (406) 258-4789 | Nicholas Zakovich, 401 Railroad St W, Missoula, MT 59802-4109 Ph: (406) 258-4789 |
News Archive
New research published Online First in The Lancet indicates that babies born to mothers who are overweight or obese in sub-Saharan Africa, where rates of obesity are projected to increase at an alarming rate during the next two decades, are significantly more likely to die in the first two days after their birth. The study is the first to shed light on the role of maternal obesity in neonatal death (during the first 28 days of life) in developing countries.
Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers.
Neurotez, Inc. today announced the grant of U.S. Patent number 8,227,408 by the United States Patent and Trademark Office covering the company's lead product candidate, Leptin. The patent protects use of the hormone Leptin for treating a progressive cognitive disease, disorder or condition, such as Alzheimer's disease (AD), resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid peptide in brain.
Upconversion emission materials are ideal for bioimaging due to its effectiveness as contrast agents for the detection of cancer cells, more so when the background emission of non-cancerous tissues can be minimised. These materials could be used as biomarkers for luminescent labeling of cancerous cells. Opaque tissues can be turned into glassy, transparent substances by using these biomarkers which rely on near-infrared excitation.
HIV-positive people who received healthy food and snacks for six months were more likely to adhere to their medication regimens, and they, as well as people with type 2 diabetes, were less depressed and less likely to make trade-offs between food and healthcare, according to a new study led by researchers at UC San Francisco.
› Verified 4 days ago
Mark Dalton, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-543-7271 Fax: 406-327-1834 | |
Kimberly Webb Floyd, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway, Missoula, MT 59802 Phone: 406-543-7271 | |
Rebecca G Anderson, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-543-7271 | |
Dr. Meredith Alexia Lease, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 3075 N Reserve St Ste Q, Missoula, MT 59808 Phone: 406-327-1850 Fax: 406-327-1875 | |
Timothy J Caramore, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 445 W Alder St, Missoula, MT 59802 Phone: 406-510-1800 Fax: 406-926-1114 |